Catalyst to Speak on FDA & Innovation, Market Trends Affecting the Future of Health Care, and RWE in Drug Development

Catalyst Healthcare Consulting will be speaking at a number of events this spring and summer. Come join us as we explore some of the key issues and trends impacting the environment for medical product development.

Catalyst President Nancy Bradish Myers will moderate or participate in several panels at US and international conferences over the next few months:

  • DIA China 2018, Beijing:
    • Panelist: “Real-world Evidence Defined and Re-defined: Regulatory and Practical Considerations for Drug Development”
2018-04-11T19:05:13+00:00